News
Rallies, motorsport festivals and other types of meet-ups give fans of classic automobiles ample opportunity to admire ...
Two performance monsters meet on the street! The sleek Vorsteiner Audi R8 V10 Performance takes on the brutally tuned 750HP ...
8d
MotorTrend on MSN2025 Audi Q6 E-Tron First Look: Elevated EV GameAudi Q6 E-Tron is more than an electric midsize luxury SUV. It represents the future of Audi and of the larger Volkswagen ...
The Realme Narzo 80 series is making its debut in India later today. The line-up will include the Realme Narzo 80 Pro 5G and Narzo 80x 5G. The Realme Narzo 80 Pro 5G will debut as the second ...
"We’re looking forward to a whole series of events that are being put on across Adur and Worthing in recognition of the 80th anniversary of VE Day this May,” the councils said in a social media post. ...
Investors in the Series C were drawn to the deal largely due to Hydrolix's success in building sales momentum behind a comprehensive channel strategy. The cornerstone of that strategy is a ...
After a short pre-production period, the Quattro made its debut at the 1980 Geneva Motor Show, just months before the start of the 1981 rally ... series – he explained that since the Quattro ...
Underscoring the growing influence of AI in the insurance sector, AI-driven commercial trucking insurer Nirvana Insurance announced on Monday an $80 million Series C funding round. This latest round ...
Huawei is set to release its new Pura 80 series smartphone this year. The device will feature big improvements in display, fingerprint recognition, and camera technology. With these updates ...
Ford’s big-buck, four-car effort at this year’s race was highly publicized, as were the last few years of Audi’s similarly intensive ... s inclusion in the newly formed World Rally-Raid Championship, ...
GrayQuest, a fintech company focused on building digital financial solutions for India’s education ecosystem, said it raised ₹80 crore ($9.3 million) in its Series B equity funding round.
Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results